Zobrazeno 1 - 10
of 207
pro vyhledávání: '"M. Berrettini"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
M. Berrettini, Alberto Burlina, Guiseppe Cella, William Strauss, Giovanna Motta, Antonio Girolami, Alessandra Sbarai
Publikováno v:
Thrombosis Research. 98:375-381
Thrombotic events are a well-recognized complication of homocystinuria. However, the mechanisms involved in the atherogenic and thrombotic effects of homocyst(e)ine remain incompletely understood. The objective of this study was to determine the role
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::daff8e2c6d71336f698a1d16e1c217a9
https://doi.org/10.1016/s0049-3848(00)00188-2
https://doi.org/10.1016/s0049-3848(00)00188-2
Publikováno v:
Blood. 92:1646-1651
In three Italian patients, two point mutations and a short deletion were found in the intron 7 of factor VII gene, clustered in the donor splice site and located in the first of several repeats. The mutation 9726+5G→A, the most frequent cause of sy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::45f22434083f5b114ac2b152ac329a74
https://doi.org/10.1182/blood.v92.5.1646
https://doi.org/10.1182/blood.v92.5.1646
Autor:
Nicoletta Erba, Gualtiero Palareti, Gianluigi Devoto, Serena Musolesi, Nicoletta Leali, M. Berrettini, Sergio Coccheri, Marco Moia, Mario Poggi, Armando D'Angelo, Cesare Manotti, N. Ciavarella, Vittorio Pengo
Publikováno v:
The Lancet. 348:423-428
Summary Background Bleeding is the most serious complication of the use of oral anticoagulation in the prevention and treatment of thromoboembolic complications. We studied the frequency of bleeding complications in outpatients treated routinely in a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0629e484920c9456295853d12c3d5d3c
https://doi.org/10.1016/s0140-6736(96)01109-9
https://doi.org/10.1016/s0140-6736(96)01109-9
A Simple Chromogenic Substrate Assay of Tissue Factor Pathway Inhibitor Activity in Plasma and Serum
Autor:
Walter Kisiel, M. Berrettini, P. Parise, Giuseppe G. Nenci, Graziella Lucarelli, Morena Malaspina
Publikováno v:
American Journal of Clinical Pathology. 103:391-395
A simple chromogenic substrate assay for the quantitation of tissue factor pathway inhibitor (TFPI) activity in plasma or serum samples was developed. After immobilization on microtiter plates for 20 hours at 4 °C, a commercial thromboplastin was in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2657a7407df5945e60613ccdc45ed0c7
https://doi.org/10.1093/ajcp/103.4.391
https://doi.org/10.1093/ajcp/103.4.391
Publikováno v:
Journal of Biological Chemistry. 267:19833-19839
Endothelial cells expose specific receptors for blood clotting factors and, upon perturbation, can initiate and propagate the reactions of the extrinsic pathway of blood coagulation leading to fibrin formation on the cell surface. The existence of an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1bbde3470f8e6115bd77ca21e2c1ff02
https://doi.org/10.1016/s0021-9258(19)88630-1
https://doi.org/10.1016/s0021-9258(19)88630-1
Publikováno v:
European Journal of Clinical Pharmacology. 39:495-500
Picotamide (G 137), a new non prostanoid inhibitor of in vitro arachidonic acid induced platelet aggregation, has been further characterized in in vitro and ex vivo studies. When whole blood was activated with collagen in the presence of picotamide 5
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1e93bf56e2de6f8fc0b2b9cae43d1c80
https://doi.org/10.1007/bf00280943
https://doi.org/10.1007/bf00280943
Autor:
Guido Finazzi, Vincenzo Brancaccio, Finn Wisløff, Sophie Testa, Jacek Musiał, T Barbui, Armando D'Angelo, Piercarla Schinco, M. Berrettini, G. Tognoni, Roberto Marchioli, F. Baudo
Publikováno v:
Journal of thrombosis and haemostasis : JTH. 3(5)
Summary. Background: The optimal intensity of oral anticoagulation for the prevention of recurrent thrombosis in patients with antiphospholipid antibody syndrome is uncertain. Retrospective studies show that only high-intensity oral anticoagulation [
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eb54a3bd26658dfd9978d1c3ee2f6dab
https://pubmed.ncbi.nlm.nih.gov/17531169
https://pubmed.ncbi.nlm.nih.gov/17531169